Connection

William Rieter to Radiopharmaceuticals

Back to Details
This is a "connection" page, showing publications William Rieter has written about Radiopharmaceuticals.
William Rieter
Connection Strength
0.265
Radiopharmaceuticals
  1. Antiseptic-Mediated Colloid Labeling as a Potential Source of Abnormal Liver and Spleen Uptake with 99mTc-Dimercaptosuccinic Acid. J Nucl Med Technol. 2021 Sep; 49(3):290-291.
    View in: PubMed
    Score: 0.174
  2. Risk of Radiation Exposure to Clinical Staff from Paracenteses of Large-Volume Chylous Ascites After 177Lu-DOTATATE Infusion. J Nucl Med Technol. 2022 Sep; 50(3):274-277.
    View in: PubMed
    Score: 0.046
  3. Prospective Evaluation of the First Integrated Positron Emission Tomography/Dual-Energy Computed Tomography System in Patients With Lung Cancer. J Thorac Imaging. 2021 Nov 01; 36(6):382-388.
    View in: PubMed
    Score: 0.045
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.